IRIS Institutional Research Information System - OPENBS Open Archive UniBS

SALVI, ALESSANDRO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.416
EU - Europa 4.994
AS - Asia 3.718
SA - Sud America 784
AF - Africa 70
Continente sconosciuto - Info sul continente non disponibili 17
OC - Oceania 13
AN - Antartide 1
Totale 15.013
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.277
PL - Polonia 1.409
CN - Cina 1.268
SG - Singapore 1.200
DE - Germania 1.022
UA - Ucraina 667
BR - Brasile 666
IT - Italia 557
HK - Hong Kong 341
FI - Finlandia 304
VN - Vietnam 251
GB - Regno Unito 249
RU - Federazione Russa 237
IN - India 218
FR - Francia 171
TR - Turchia 160
IE - Irlanda 106
SE - Svezia 86
CA - Canada 80
ID - Indonesia 64
BE - Belgio 47
AR - Argentina 46
BD - Bangladesh 45
MX - Messico 42
AT - Austria 28
ZA - Sudafrica 25
IQ - Iraq 23
NL - Olanda 23
ES - Italia 22
EC - Ecuador 20
JP - Giappone 20
RO - Romania 20
EU - Europa 17
PY - Paraguay 13
AU - Australia 12
IR - Iran 12
PK - Pakistan 12
SA - Arabia Saudita 12
KR - Corea 11
AE - Emirati Arabi Uniti 10
CO - Colombia 10
CZ - Repubblica Ceca 10
KE - Kenya 10
CL - Cile 8
MA - Marocco 8
AZ - Azerbaigian 7
LT - Lituania 7
TH - Thailandia 7
UZ - Uzbekistan 7
IL - Israele 6
JO - Giordania 6
MU - Mauritius 6
OM - Oman 6
VE - Venezuela 6
LY - Libia 5
PE - Perù 5
TN - Tunisia 5
UY - Uruguay 5
BO - Bolivia 4
EG - Egitto 4
GR - Grecia 4
JM - Giamaica 4
KZ - Kazakistan 4
AM - Armenia 3
BG - Bulgaria 3
CH - Svizzera 3
CR - Costa Rica 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
LK - Sri Lanka 3
MY - Malesia 3
RS - Serbia 3
AL - Albania 2
BY - Bielorussia 2
GE - Georgia 2
HN - Honduras 2
HU - Ungheria 2
KG - Kirghizistan 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
PH - Filippine 2
SD - Sudan 2
TJ - Tagikistan 2
TW - Taiwan 2
AQ - Antartide 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CG - Congo 1
DK - Danimarca 1
DM - Dominica 1
EE - Estonia 1
GT - Guatemala 1
IM - Isola di Man 1
LV - Lettonia 1
MK - Macedonia 1
NI - Nicaragua 1
NO - Norvegia 1
NP - Nepal 1
Totale 15.004
Salva come PNG Salva come JPEG
Città #
Warsaw 1.407
Singapore 548
Jacksonville 452
Ashburn 434
Fairfield 378
Chandler 361
Hong Kong 334
Woodbridge 311
Beijing 309
Ann Arbor 276
Houston 209
Princeton 196
New York 195
Brescia 194
Helsinki 185
Wilmington 183
Nanjing 169
Cambridge 164
Los Angeles 157
Seattle 142
Istanbul 113
Dublin 106
Munich 104
Dearborn 87
The Dalles 81
Des Moines 80
Buffalo 79
Ho Chi Minh City 77
Chicago 72
Dong Ket 70
Dallas 62
São Paulo 61
Nanchang 53
San Francisco 53
Changsha 52
Shanghai 51
Milan 50
Shenyang 50
Jakarta 46
Jinan 46
Moscow 46
Brussels 45
Hebei 42
Lancaster 40
Tianjin 39
Redondo Beach 38
Pune 37
Hanoi 32
Jiaxing 32
Santa Clara 30
Brooklyn 27
Turku 27
Toronto 26
Kunming 25
Salt Lake City 25
San Diego 25
Kocaeli 24
Rio de Janeiro 24
Lappeenranta 22
Hangzhou 21
Nuremberg 20
Mexico City 19
Nürnberg 18
Phoenix 18
Guangzhou 17
London 17
North York 17
Zhengzhou 17
Johannesburg 16
Montreal 16
Ningbo 16
Tokyo 16
Boston 15
Verona 15
Boardman 14
Tampa 14
Vienna 14
Belo Horizonte 13
Chennai 13
Romola 12
Atlanta 11
Bari 11
Denver 11
Orem 11
Poplar 11
Amsterdam 10
Charlotte 10
Elk Grove Village 10
Falkenstein 10
Frankfurt am Main 10
Porto Alegre 10
Rome 10
Stockholm 10
Curitiba 9
Manchester 9
Riyadh 9
Taizhou 9
Ankara 8
Brasília 8
Guayaquil 8
Totale 9.136
Salva come PNG Salva come JPEG
Nome #
Mutation analysis by direct and whole exome sequencing in familial and sporadic tooth agenesis 341
Cultured human amniocytes express hTERT, which is distributed between nucleus and cytoplasm and is secreted in extracellular vesicles 321
Sorafenib induces variations of the DNA methylome in HA22T/VGH human hepatocellular carcinoma-derived cells 314
Plasma NfL, GFAP, amyloid, and p-tau species as Prognostic biomarkers in Parkinson’s disease 263
Analysis of a nanoparticle-enriched fraction of plasma reveals miRNA candidates for Down syndrome pathogenesis 262
Proteomic identification of LASP-1 down-regulation after RNAi urokinase silencing in human hepatocellular carcinoma cells. 255
Clinical and biological significance of miR-23b and miR-193a in human hepatocellular carcinoma 233
Circulating miR-106b-3p, miR-101-3p and miR-1246 as diagnostic biomarkers of hepatocellular carcinoma 229
Functional Role of microRNA-23b-3p in Cancer Biology 217
RET/PTC-1-driven transformation and pro-invasive phenotype of human thyrocytes depend on MET induction and alpha-catenin nuclear translocation 209
Effects of miR-193a and sorafenib on hepatocellular carcinoma cells. 207
Circulating ncRNAs as promising non-invasive molecular biomarkers of HCC 196
Long non-coding RNA GAS5 and miR-126-3p as molecular biomarkers of response to sorafenib in human cancer cells. 193
Circulating ncRNAs as promising non-invasive molecular biomarkers of HCC 190
Differential expression of miR-24 and miR27a in cirrhotic/non cirrhotic HCC 188
Biological Function of MicroRNA193a-3p in Health and Disease 187
Long non-coding RNA GAS5 and miR-126-3p as molecular biomarkers of response to sorafenib in human cancer cells. 185
miR-193a sensitizes hepatocellular carcinoma cells to sorafenib and impairs their aggressive properties. 182
Differential expression of miR-24 and miR27a in cirrhotic/non cirrhotic HCC. 176
miR103 e miR-107 sono coinvolti nella regolazione dell'espressione di CDK5R1/p35 implicato nella migrazione neuronale. 172
Human hepatocellular carcinoma cell-specific miRNAs reveal the differential expression of miR-24 and miR-27a in cirrhotic/non-cirrhotic HCC 172
MicroRNAs as Biomarkers of hepatocellular carcinoma and molecular targeted therapeutics with sorafenib 167
microRNAs and human hepatocellular carcinoma 165
Differential expression profiling of long non-coding RNA GAS5 and miR-126-3p in human cancer cells in response to sorafenib 160
LASP1 directly interacts with vimentin and its expression stratifies patients affected by human hepatocellular carcinoma 154
The study of HCC-cell specific miRs reveals one novel human miR and miR-21, miR-24 and miR-27a differential expression in HCC. 151
The study of HCC cell specific miRNas reveals one novel human miR and miR-21, miR24 and miR-27a differential expression in HCC 151
BRCA1 and BRCA2 genetic test in high risk patients and families : counselling and management 151
Study of the in vitro modulation exerted by the antidepressant drug escitalopram on the expression of candidate microRNAs and their target genes 149
Circulating microRNAs as promising non-invasive molecular biomarkers of HCC 148
miR24, MiR 27a e miR193a nell'HCC: potenzialità prognostiche e terapeutiche. 144
In vitro c-met inhibition by antisense RNA and plasmid -based RNAi down modulates migration and invasion of hepatocellular carcinoma cells. 142
MicroRNA 193a negatively regulates urokinase and in combination with sorafenib impairs the aggressive properties of HCC cells 142
The analysis of HCC-cell specific miRs reveals one novel human miR and miR-21, miR-24, and miR-27a differential expression in cirrhotic/non- cirrhotic HCC. 141
Molecular characterization of LASP-1 expression reveals vimentin as its new partner in human hepatocellular carcinoma cells. 141
Does miR-338, a putative negative regulator of the facilitative glucose transporter 10 (GLUT10), play a role in arterial tortuosity syndrome? 139
Melatonin Effects on Non-Alcoholic Fatty Liver Disease Are Related to MicroRNA-34a-5p/Sirt1 Axis and Autophagy 138
RT-PCR detection of telomerase in intraductal papillary mucinous tumours (IPMT) of the pancreas: preliminary findings. 137
miR-193a sensitizes hepatocellular carcinoma cells to sorafenib and impairs their aggressive properties. 132
Antisense u-PA mRNA strategy inhibits the proliferation and invasion of human hepatocellular carcinoma cells. 130
Sequential analysis of multistage hepatocarcinogenesis reveals that miR100 and PLK1 dysregulation is an early event maintained along tumor progression. 130
FUNCTIONAL ROLE OF MICRORNA-23b-3p and MICRORNA-193a-3p IN CELL MIGRATION OF CANCER CELLS 128
Sequential analysis of multistage hepatocarcinogenesis reveals that miR-100 and PLK-1 dysregulation is an early event maintained along tumor progression. 127
The combined use of miR-193a and sorafenib displays in vitro anticancer effects in hepatocellular carcinoma. 125
Stable expression of antisense urokinase mRNA inhibits the proliferation and invasion of human hepatocellular carcinoma cells 124
Determination of plasmatic microRNA levels by ddPCR as peripheral biomarkers for IDH-wild type glioblastomas: a pilot study 124
MicroRNA-23b mediates urokinase and c-met downmodulation and a decreased migration of human hepatocellular carcinoma cells. 121
The role of miR-103 and miR-107 in regulation of CDK5R1 expression and in cellular migration. 121
Identification and molecular characterization of cryptic chromosomal rearrangements in mental retardation patients. 118
H-ferritin suppression and pronounced mitochondrial respiration make Hepatocellular Carcinoma cells sensitive to RSL3-induced ferroptosis 118
Urokinase and c-met are target of miR-23b in human cells. 115
Evidence on microRNAs mediated regulation of CDK5R1 gene expression. 115
Germline and somatic c-met mutations in multifocal/bilateral and sporadic papillary renal carcinomas of selected patients. 114
Characterization and development of miRNA-like shRNA for urokinase targeting in human hepatocellular carcinoma 114
Stable expression of siRNA for urokinase gene in human hepatocellular carcinoma. 113
miRNAs-Based Molecular Signature for KRAS Mutated and Wild Type Colorectal Cancer: An Explorative Study 109
Urokinase targeting in human hepatocellular carcinoma by shRNAs/miR-23b and proteomic identification of LASP1 as uPA effector. 108
DNA methylation variations in familial female and male breast cancer 108
RNA interference against urokinase in hepatocellular carcinoma xenografts in nude mice. 107
MicroRNA ed Epatocarcinoma: il microRNA-23b media la downmodulazione di urochinasi e c-met e la capacità di migrazione di cellule derivate da HCC 107
Il silenziamento di urochinasi in cellule tumorali epatiche determina la downmodulazione di Lasp-1 106
Downregulation of urokinase by antisense and RNAi strategies inhibits the proliferation and migration of human hepatocellular carcinoma cells. 105
Evidence on microRNAs mediated regulation of CDK5R1 gene expression. 104
Espressione stabile di siRNA per il gene urochinasi nell'epatocarcinoma cellulare 103
MicroRNA-23b downmodulates urokinase and c-met and inhibits migration of human hepatocellular carcinoma cells. 102
L'espressione stabile della sequenza antisenso dell'mRNA dell'u-PA inibisce la proliferazione e l'invasione di cellule di epatocarcinoma umano. 100
L'espressione stabile di RNA antisenso e di siRNA per u-PA inibisce la proliferazione , la migrazione e l'invasione di cellule di epatocarcinoma umano. 100
Endocannabinoid system in inflammatory bowel diseases: mucosal gene expression preliminary data 99
Specific downregulation of urokinase by stable expression of antisense u-PA mRNA and u-PA siRNA inhibits proliferation, invasion,and migration of human hepatocellular carcinoma. 99
Genes and MiRNAs in mental retardation patients with cryptic chromosome imbalances detected by SNP-based array analysis. 99
Evidence on microRNAs mediated regulation of CDK5R1 gene expression 98
Il microRNA-23b media la downmodulazione di urochinasi e met ed inibisce la migrazione di cellule umane derivate da epatocarcinoma cellulare. 98
Molecular therapies for hepatocellular carcinoma: silencing of urokinase by antisense and siRNA stable u-PA expression. 98
Plasmatic microRNA levels by ddPCR as peripheral biomarkers for IDH-wild type glioblastomas: a pilot study 97
MET silencing in human hepatocellular carcinoma: antisense and RNA interference 97
MicroRNA-23b negatively regulates urokinase and c-met and inhibits migration of human hepatocellular carcinoma cells. 96
Inherited duplication of the pseudoautosomal region Xq28 in a subject with Gilles de la Tourette syndrome and intellectual disability: A case report 96
Expression of Cellular and Extracellular TERRA, TERC and TERT in Hepatocellular Carcinoma 95
Evidence on microRNAs mediated regulation of CDK5R1 gene expression 95
MicroRNA-23b mediates urokinase and MET downmodulation and inhibits migration of human hepatocellular carcinoma cells. 95
Circulating microRNA-23b-3p and tissue microRNA-193a-3p as promising molecular biomarkers in human hepatocellular carcinoma. 94
RNA interference per il gene urochinasi nell'epatocarcinoma cellulare umano 94
Emerging role of Telomeric-Repeat containing RNA TERRA in hepatocellular carcinoma 94
miR-23b regulates uPA and c-met expression and mediates inhibition of HCC cells migration and proliferation. 93
miR-23b down-regulates urokinase and c-met expression and inhibits migration of human hepatocellular carcinoma cells. 92
MicroRNA‑34a‑5p expression in the plasma and its extracellular vesicle fractions in subjects with Parkinson's disease: An exploratory study 92
Evidence on microRNAs mediated regulation of CDK5R1 gene expression 91
Targeted therapy for human hepatocellular carcinoma (HCC): RNA interference for urokinase targeting in HCC xenografts in nude mice 90
Telomerase gene expression in intraductal papillary-mucinous tumors (IPMT): preliminary findings 90
The study of HCC-cell specific miRs reveals one novel human miR and miR-21, miR-24 and miR-27a differential expression in HCC 90
RNA interference for urokinase gene in human hepatocellular carcinoma 88
L'espressione stabile di siRNA per il gene urochinasi diminuisce la capacità invasiva e di migrazione di cellule di epatocarcinoma cellulare umano. 87
RNA interference for urokinase targeting limits growth of hepatocellular carcinoma xenografts in nude mice 86
Stable expression of siRNA for urokinase gene in human hepatocellular carcinoma 85
Molecular therapies for hepatocellular carcinoma: silencing of urokinase by antisense and siRNA stable u-PA expression. 85
Longitudinal Circulating Levels of miR-23b-3p, miR-126-3p and lncRNA GAS5 in HCC Patients Treated with Sorafenib 84
Crosstalk Between DNA Methylation and Gene Mutations in Colorectal Cancer 84
Profilo proteomico di cellule umane tumorali epatiche dopo silenziamento genico di urochinasi mediante RNAi 83
Strategie ablative per il silenziamento genico di c-met nell'epatocarcinoma cellulare umano: tecnologia antisenso ed RNAi. 81
Molecular therapies for hepatocellular carcinoma: silencing of urokinase-type plasminogen activator by antisense and siRNA stable u-PA expression 81
Totale 13.566
Salva come PNG Salva come JPEG
Categoria #
all - tutte 62.841
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 62.841
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.089 0 0 0 0 0 182 68 194 229 187 124 105
2021/2022847 48 155 47 47 7 30 25 52 48 91 94 203
2022/2023949 132 56 34 84 88 225 13 81 138 7 39 52
2023/20241.050 74 27 111 62 46 231 68 34 173 49 25 150
2024/20252.739 37 50 49 384 216 240 199 74 332 144 663 351
2025/20262.899 475 668 379 744 527 106 0 0 0 0 0 0
Totale 15.279